Q4 2017 Edge Therapeutics Inc Earnings Call

1/3/2018 8:30

Conference Call Edge Therapeutics Inc

Edge Therapeutics Inc Conference call or earnings call will be held on Mar 1, 2018 via an 800 number (toll-free). During the earnings conference call's session Edge Therapeutics Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Edge Therapeutics Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening conditions. Our initial product candidates target rare, acute, life-threatening neurological conditions for which we believe the approved existing therapies, if any, are inadequate. We believe EG-1962, our lead product candidate, can fundamentally improve patient outcomes and transform the management of aneurysmal subarachnoid hemorrhage, or aSAH, which is bleeding around the brain due to a ruptured brain aneurysm. A single dose of EG-1962 is designed to deliver high concentrations of nimodipine, the current standard of care, directly to the brain with sustained drug exposure over 21 days.    
Read more Conference Call

Edge Therapeutics Inc (EDGE)

200 Connell Drive, Berkeley Heights New Jersey 07922, United States